交易 ANI Pharma - ANIP CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.22 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
ANI Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 19, 2024 | 65.31 | 1.36 | 2.13% | 63.95 | 65.64 | 63.95 |
Apr 18, 2024 | 64.49 | -0.46 | -0.71% | 64.95 | 65.84 | 64.31 |
Apr 17, 2024 | 65.26 | -0.20 | -0.31% | 65.46 | 65.99 | 64.97 |
Apr 16, 2024 | 65.51 | -0.29 | -0.44% | 65.80 | 66.43 | 65.45 |
Apr 15, 2024 | 66.25 | -0.20 | -0.30% | 66.45 | 67.26 | 65.59 |
Apr 12, 2024 | 66.83 | 0.10 | 0.15% | 66.73 | 68.05 | 66.42 |
Apr 11, 2024 | 67.91 | 0.98 | 1.46% | 66.93 | 68.03 | 66.51 |
Apr 10, 2024 | 66.82 | 0.86 | 1.30% | 65.96 | 66.91 | 65.96 |
Apr 9, 2024 | 66.91 | -0.34 | -0.51% | 67.25 | 67.46 | 66.69 |
Apr 8, 2024 | 67.47 | -0.16 | -0.24% | 67.63 | 68.22 | 67.11 |
Apr 5, 2024 | 67.46 | -0.45 | -0.66% | 67.91 | 68.02 | 66.20 |
Apr 4, 2024 | 67.81 | 0.60 | 0.89% | 67.21 | 68.09 | 66.83 |
Apr 3, 2024 | 67.06 | 0.74 | 1.12% | 66.32 | 67.28 | 66.32 |
Apr 2, 2024 | 66.51 | -0.52 | -0.78% | 67.03 | 67.15 | 66.34 |
Apr 1, 2024 | 67.78 | -1.17 | -1.70% | 68.95 | 68.95 | 66.39 |
Mar 28, 2024 | 69.01 | 0.03 | 0.04% | 68.98 | 69.74 | 68.95 |
Mar 27, 2024 | 69.64 | 0.12 | 0.17% | 69.52 | 69.92 | 69.28 |
Mar 26, 2024 | 69.41 | -0.16 | -0.23% | 69.57 | 70.14 | 68.90 |
Mar 25, 2024 | 69.42 | 0.52 | 0.75% | 68.90 | 70.25 | 68.74 |
Mar 22, 2024 | 69.45 | 0.25 | 0.36% | 69.20 | 70.33 | 69.20 |
ANI Pharma Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 6, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 ANI Pharmaceuticals Inc Earnings Release Q1 2024 ANI Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
Tuesday, May 21, 2024 | ||
時間 (UTC) 13:00 | 國家 US
| 事件 ANI Pharmaceuticals Inc Annual Shareholders Meeting ANI Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Wednesday, May 22, 2024 | ||
時間 (UTC) 13:00 | 國家 US
| 事件 ANI Pharmaceuticals Inc Annual Shareholders Meeting ANI Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Wednesday, August 7, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 ANI Pharmaceuticals Inc Earnings Release Q2 2024 ANI Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 316.385 | 216.136 | 208.475 | 206.547 | 201.576 |
收入 | 316.385 | 216.136 | 208.475 | 206.547 | 201.576 |
收入成本,共計 | 138.785 | 100.61 | 87.157 | 63.154 | 73.024 |
毛利 | 177.6 | 115.526 | 121.318 | 143.393 | 128.552 |
總營業費用 | 351.668 | 255.929 | 224.491 | 190.196 | 166.217 |
銷售/一般/行政費用,總計 | 124.044 | 84.294 | 64.986 | 55.843 | 44.063 |
研究與開發 | 22.318 | 11.369 | 16.001 | 19.806 | 15.388 |
Depreciation / Amortization | 56.972 | 47.252 | 44.638 | 44.612 | 33.742 |
異常費用(收入) | 5.791 | 11.904 | 11.709 | 6.781 | 0 |
營業收入 | -35.283 | -39.793 | -16.016 | 16.351 | 35.359 |
利息收入(費用),非經營淨值 | -28.052 | -11.922 | -9.452 | -12.966 | -14.758 |
其他,淨值 | 0.67 | -4.343 | -0.494 | -0.228 | -0.55 |
稅前淨收入 | -62.665 | -56.058 | -25.962 | 3.157 | 20.051 |
稅後淨收入 | -47.896 | -42.603 | -22.548 | 6.094 | 15.494 |
未計算非常項目前的淨收益 | -47.896 | -42.603 | -22.548 | 6.094 | 15.494 |
淨收入 | -47.896 | -42.603 | -22.548 | 6.094 | 15.494 |
普通股股東可獲收益 (不含非經常性項目) | -49.521 | -42.793 | -22.548 | 5.997 | 15.34 |
普通股股東可獲收益 (含非經常性項目) | -49.521 | -42.793 | -22.548 | 5.997 | 15.34 |
攤薄淨收入 | -49.521 | -42.793 | -22.548 | 5.997 | 15.34 |
攤薄後加權平均股 | 16.26 | 12.596 | 11.964 | 12.04 | 11.772 |
扣除特別項目的每股攤薄盈利 | -3.04557 | -3.39735 | -1.88465 | 0.49809 | 1.30309 |
每股正常攤薄盈利 | -2.81407 | -2.78306 | -1.24851 | 0.86417 | 1.30309 |
非常規項目總計 | |||||
Total Adjustments to Net Income | -1.625 | -0.19 | -0.097 | -0.154 | |
Other Operating Expenses, Total | 3.758 | 0.5 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 116.547 | 106.786 | 94.232 | 83.821 | 73.855 |
收入 | 116.547 | 106.786 | 94.232 | 83.821 | 73.855 |
收入成本,共計 | 42.284 | 37.708 | 36.326 | 32.894 | 35.294 |
毛利 | 74.263 | 69.078 | 57.906 | 50.927 | 38.561 |
總營業費用 | 104.145 | 96.891 | 92.412 | 88.816 | 86.768 |
銷售/一般/行政費用,總計 | 38.76 | 36.468 | 33.188 | 30.081 | 31.958 |
研究與開發 | 7.374 | 5.924 | 5.222 | 7.657 | 4.165 |
Depreciation / Amortization | 14.69 | 14.7 | 14.484 | 14.167 | 13.764 |
異常費用(收入) | 0.002 | 1.13 | 1.568 | 1.541 | 2.682 |
營業收入 | 12.402 | 9.895 | 1.82 | -4.995 | -12.913 |
利息收入(費用),非經營淨值 | -7.1 | -7.696 | -7.506 | -7.264 | -6.669 |
其他,淨值 | -0.053 | -0.034 | -0.042 | 0.037 | 0.764 |
稅前淨收入 | 5.249 | 2.165 | -5.728 | -12.222 | -18.818 |
稅後淨收入 | 6.245 | 1.439 | -4.243 | -8.6 | -14.923 |
未計算非常項目前的淨收益 | 6.245 | 1.439 | -4.243 | -8.6 | -14.923 |
淨收入 | 6.245 | 1.439 | -4.243 | -8.6 | -14.923 |
普通股股東可獲收益 (不含非經常性項目) | 5.838 | 1.033 | -4.65 | -9.006 | -15.33 |
普通股股東可獲收益 (含非經常性項目) | 5.838 | 1.033 | -4.65 | -9.006 | -15.33 |
攤薄淨收入 | 5.838 | 1.033 | -4.65 | -9.006 | -15.33 |
攤薄後加權平均股 | 17.855 | 16.531 | 16.326 | 16.303 | 16.272 |
扣除特別項目的每股攤薄盈利 | 0.32697 | 0.06249 | -0.28482 | -0.55241 | -0.94211 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
每股正常攤薄盈利 | 0.32704 | 0.10792 | -0.22239 | -0.49097 | -0.83497 |
Other Operating Expenses, Total | 1.035 | 0.961 | 1.624 | 2.476 | -1.095 |
Total Adjustments to Net Income | -0.407 | -0.406 | -0.407 | -0.406 | -0.407 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 344.261 | 321.775 | 170.321 | 187.695 | 152.877 |
現金和短期投資 | 48.228 | 100.3 | 7.864 | 62.332 | 43.008 |
現金等價物 | 48.228 | 100.3 | 7.864 | 62.332 | 43.008 |
應收賬款總額,淨額 | 169.265 | 132.193 | 95.793 | 73.205 | 64.842 |
應收賬款 - 貿易,淨額 | 165.438 | 128.526 | 95.793 | 72.129 | 64.842 |
總庫存 | 105.355 | 81.693 | 60.803 | 48.163 | 40.503 |
預付的費用 | 8.387 | 7.589 | 5.861 | 3.995 | 4.524 |
總資産 | 760.087 | 771.598 | 461.19 | 456.789 | 430.604 |
物業/廠房/設備,總計 - 淨額 | 43.246 | 52.671 | 41.269 | 40.551 | 38.09 |
物業/廠房/設備,總計 - 總額 | 75.958 | 75.627 | 58.796 | 53.321 | 46.491 |
累計折舊,總計 | -32.712 | -22.956 | -17.527 | -12.77 | -8.401 |
商譽,淨額 | 28.221 | 27.888 | 3.58 | 3.58 | 3.58 |
無形資産,淨額 | 251.635 | 294.122 | 188.511 | 180.388 | 201.604 |
其他長期資産,總計 | 92.724 | 75.142 | 57.509 | 44.575 | 34.453 |
流動負債總額 | 99.439 | 87.537 | 78.565 | 61.676 | 165.549 |
應付賬款 | 29.305 | 22.967 | 11.261 | 14.606 | 8.884 |
預提費用 | 35.885 | 27.802 | 22.92 | 20.083 | 22.661 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 33.399 | 35.918 | 31.141 | 17.046 | 18.285 |
負債總額 | 421.547 | 412.858 | 265.49 | 243.998 | 233.341 |
長期債務總額 | 285.669 | 286.52 | 172.443 | 175.808 | 67.296 |
長期債務 | 285.669 | 286.52 | 172.443 | 175.808 | 67.296 |
其他負債,總計 | 36.439 | 38.801 | 14.482 | 6.514 | 0.496 |
股權 | 338.54 | 358.74 | 195.7 | 212.791 | 197.263 |
Preferred Stock - Non Redeemable, Net | 24.85 | 24.85 | 0 | 0 | |
普通股 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
額外實收資本 | 403.901 | 387.844 | 214.354 | 200.8 | 186.812 |
留存收益(累計赤字) | -97.286 | -47.765 | -4.972 | 17.584 | 11.488 |
總負債和股東權益 | 760.087 | 771.598 | 461.19 | 456.789 | 430.604 |
已發行普通股總數 | 17.5053 | 16.8406 | 12.3653 | 12.1004 | 11.8622 |
長期債務的當前部分/資本租賃 | 0.85 | 0.85 | 13.243 | 9.941 | 115.719 |
Treasury Stock - Common | -5.094 | -3.135 | -2.246 | -0.723 | -0.659 |
其他權益,總計 | 12.168 | -3.055 | -11.437 | -4.871 | -0.379 |
Total Preferred Shares Outstanding | 0.025 | 0.025 | |||
其他流動資産,總計 | 13.026 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 497.22 | 459.311 | 364.753 | 344.261 | 309.377 |
現金和短期投資 | 193.078 | 161.707 | 67.757 | 48.228 | 56.281 |
現金等價物 | 193.078 | 161.707 | 67.757 | 48.228 | 56.281 |
應收賬款總額,淨額 | 178.842 | 177.013 | 178.448 | 169.265 | 144.211 |
應收賬款 - 貿易,淨額 | 178.842 | 172.925 | 174.713 | 165.438 | 140.433 |
總庫存 | 106.59 | 104.323 | 103.654 | 105.355 | 95.893 |
預付的費用 | 10.69 | 8.248 | 6.874 | 8.387 | 4.972 |
總資産 | 889.914 | 859.341 | 765.224 | 760.087 | 739.11 |
物業/廠房/設備,總計 - 淨額 | 44.189 | 44.371 | 43.275 | 43.246 | 42.83 |
物業/廠房/設備,總計 - 總額 | 70.553 | 75.958 | 72.935 | ||
累計折舊,總計 | -27.278 | -32.712 | -30.105 | ||
商譽,淨額 | 28.221 | 28.221 | 28.221 | 28.221 | 28.221 |
無形資産,淨額 | 219.828 | 230.299 | 238.791 | 251.635 | 264.237 |
其他長期資産,總計 | 100.456 | 97.139 | 90.184 | 92.724 | 94.445 |
流動負債總額 | 134.352 | 122.865 | 125.825 | 99.439 | 81.627 |
應付賬款 | 34.077 | 28.505 | 32.687 | 29.305 | 18.992 |
預提費用 | 43.454 | 38.687 | 35.419 | 35.885 | 27.801 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 |
其他流動負債,總計 | 55.971 | 54.823 | 56.869 | 33.399 | 33.984 |
負債總額 | 435.203 | 424.869 | 425.742 | 421.547 | 402.435 |
長期債務總額 | 285.032 | 285.244 | 285.457 | 285.669 | 285.882 |
長期債務 | 285.032 | 285.244 | 285.457 | 285.669 | 285.882 |
其他負債,總計 | 15.819 | 16.76 | 14.46 | 36.439 | 34.926 |
股權 | 454.711 | 434.472 | 339.482 | 338.54 | 336.675 |
普通股 | 0.002 | 0.002 | 0.001 | 0.001 | 0.001 |
額外實收資本 | 506.513 | 495.488 | 408.395 | 403.901 | 399.396 |
留存收益(累計赤字) | -80.88 | -90.414 | -96.252 | -97.286 | -92.636 |
Treasury Stock - Common | -9.85 | -9.18 | -8.643 | -5.094 | -4.975 |
其他權益,總計 | 14.076 | 13.726 | 11.131 | 12.168 | 10.039 |
總負債和股東權益 | 889.914 | 859.341 | 765.224 | 760.087 | 739.11 |
已發行普通股總數 | 20.4051 | 20.2983 | 18.0033 | 17.5053 | 17.4788 |
Preferred Stock - Non Redeemable, Net | 24.85 | 24.85 | 24.85 | 24.85 | 24.85 |
Total Preferred Shares Outstanding | 0.025 | 0 | 0 | 0.025 | 0.025 |
其他流動資産,總計 | 8.02 | 8.02 | 8.02 | 13.026 | 8.02 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -47.896 | -42.603 | -22.548 | 6.094 | 15.494 |
經營活動産生的現金 | -31.203 | 3.322 | 15.267 | 45.631 | 67.074 |
經營活動産生的現金 | 59.653 | 47.252 | 44.638 | 44.612 | 33.742 |
Deferred Taxes | -15.253 | -16.754 | -13.205 | -9.134 | -5.18 |
非現金物品 | 23.593 | 15.511 | 19.01 | 18.64 | 17.05 |
Cash Taxes Paid | 0.288 | 10.371 | 4.984 | 10.033 | 6.397 |
已付現金利息 | 21.477 | 9.705 | 6.931 | 6.092 | 6.285 |
營運資金的變化 | -51.3 | -0.084 | -12.628 | -14.581 | 5.968 |
投資活動産生的現金 | -15.738 | -105.483 | -68.322 | -27.549 | -27.379 |
資本支出 | -8.876 | -2.557 | -6.135 | -6.635 | -5.743 |
其他投資現金流量項目,總計 | -6.862 | -102.926 | -62.187 | -20.914 | -21.636 |
融資活動産生的現金 | -5.126 | 194.595 | -1.439 | 1.25 | -27.816 |
融資現金流項目 | 0 | -19.384 | 0 | -1.197 | |
股票的發行(報廢),淨額 | -0.501 | 101.179 | -0.905 | 4.707 | 2.319 |
債務的發行(退還),淨額 | -3 | 112.99 | -0.534 | -3.457 | -28.938 |
現金淨變化 | -52.067 | 92.434 | -54.494 | 19.332 | 11.879 |
Total Cash Dividends Paid | -1.625 | -0.19 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 1.439 | -47.896 | -43.653 | -35.053 | -20.13 |
Cash From Operating Activities | 21.424 | -31.203 | -26.803 | -30.426 | -18.942 |
Cash From Operating Activities | 14.7 | 59.653 | 44.081 | 28.731 | 14.557 |
Deferred Taxes | 0.773 | -15.253 | -13.628 | -11.378 | -7.464 |
Non-Cash Items | 6.286 | 23.593 | 16.934 | 8.445 | 4.972 |
Cash Taxes Paid | -2.741 | 0.288 | 0.156 | 0.124 | 0 |
Cash Interest Paid | 4.293 | 21.477 | 14.028 | 11.4 | 5.637 |
Changes in Working Capital | -1.774 | -51.3 | -30.537 | -21.171 | -10.877 |
Cash From Investing Activities | -2.353 | -15.738 | -12.596 | -2.782 | -2.178 |
Capital Expenditures | -2.349 | -8.876 | -5.738 | -3.27 | -1.949 |
Other Investing Cash Flow Items, Total | -0.004 | -6.862 | -6.858 | 0.488 | -0.229 |
Cash From Financing Activities | -4.548 | -5.126 | -4.618 | -3.707 | -2.27 |
Issuance (Retirement) of Stock, Net | -3.392 | -0.501 | -1.15 | -1.395 | -1.115 |
Issuance (Retirement) of Debt, Net | -0.75 | -3 | -2.25 | -1.5 | -0.75 |
Net Change in Cash | 14.523 | -52.067 | -44.017 | -36.915 | -23.39 |
Financing Cash Flow Items | 0 | 0 | 0 | ||
Total Cash Dividends Paid | -0.406 | -1.625 | -1.218 | -0.812 | -0.405 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Pharmaceuticals (NEC) |
210 Main Street West
BAUDETTE
MINNESOTA 56623
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易